Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

E-nitiate Biopharmaceuticals (hangzhou) Co., Ltd.

Clinical trials sponsored by E-nitiate Biopharmaceuticals (hangzhou) Co., Ltd., explained in plain language.

Trials to join now! 1 Not yet finished but already full! 1 Completed 1

New oral drug aims to restore skin color in vitiligo

Disease control Recruiting now

This trial tests an experimental drug called QY201 in adults with non-segmental vitiligo, a condition that causes white patches on the skin. Participants take QY201 or a placebo tablet twice daily for 24 weeks. The main goal is to see if QY201 can reduce the amount of facial skin…

Phase: PHASE2 • Sponsor: E-nitiate Biopharmaceuticals (Hangzhou) Co., Ltd. • Aim: Disease control

Last updated Jul 19, 2026 00:00 UTC